[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Intraoperative Imaging Market by Product (Mobile C-arms, CT, Intraoperative MRI, Ultrasound, X ray), Application (Neurosurgery, Orthopedic & Trauma Care, Spine, CVDs, ENT, Gastroenterology), Enduser (Hospitals, ASCs, Academia)- Forecasts to 2025

February 2021 | 160 pages | ID: I76BD092DA1EN
MarketsandMarkets

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global intraoperative imaging market size is projected to reach USD 2.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 5.2%. Factors such as the technological advancements in the market are propelling the growth of the intraoperative imaging market. Additionally, rising cases of surgeries, investments from both private and public sectors are having affect in the growth of intraoperative imaging market. However, unfavorable reimbursement scenarios in some countries is hampering the growth of this market.

The recent COVID-19 global pandemic has also impacted the intraoperative imaging market. Demand from the main end-users has declined as key regions and countries have imposed social distancing rules and lockdowns. This impact is expected to be short-term, and no adverse effects are to be foreseen after the market gradually reopens.

“The Mobile C-arms segment to witness the highest growth rate in intraoperative imaging market, by product, during the forecast period.”

Mobile C-arms are medical imaging devices that comprise a generator, the X-ray source, and an image intensifier or flat-panel detector. The growing demand for mobile C-arms is mainly attributed to their broadening application horizons. For instance, C-arms are used for a wide range of applications, including cardiovascular surgeries, neurosurgeries, gastroenterology surgeries, orthopedics, traumatology, and urology disorders.

“The neurosurgery accounted for the largest share of the intraoperative imaging market, by application, in 2020.”

The neurosurgery segment accounted for the largest share of the intraoperative imaging market in 2020. The growing demand for intraoperative imaging solutions in neurosurgery is mainly attributed to the increasing adoption of intraoperative imaging products among medical professionals, owing to its technological advancements and rising awareness of intraoperative techniques. For instance, C-arms with high resolution and penetration are essential in monitoring the positioning of screws, instruments, implants, and the injected cement. Furthermore, 3D imaging with navigation enhances treatment precision and enables the intraoperative evaluation of surgical procedures. The use of C-arms for neurosurgery, especially spinal surgeries, is expected to increase in the coming years on account of technological advancements that have made diagnosing and treating issues easier than before.

“The Hospitals & diagnostic centers segment accounted for the largest share of the intraoperative imaging market, by end users, in 2020”

Hospitals & diagnostic centers accounted for the largest share of the intraoperative imaging market in 2020. The availability of state-of-the-art facilities for treating disorders and injuries and trained personnel has ensured a steady demand for hospital-based care. The inflow of patients is considerably higher in hospitals than in other healthcare settings, which is another key driver for market growth.

Hospitals routinely conduct a wide range of surgical procedures, and most of these surgeries are performed in hospital in-patient settings. Growth in this segment is primarily attributed to the growing number of minimally invasive surgeries and electrosurgery procedures performed in hospitals and the adoption of robotic surgery.

“The Asia Pacific market to grow at the highest CAGR during the forecast period.”

The intraoperative imaging market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Government efforts to increased funding , supportive regulations for the development and commercialization of advanced intraoperative imaging products, rising healthcare expenditure, increasing number of hospitals and clinics in India and China, expanding research base across India, China, and Japan, and the increasing incidence of surgeries are the major factors driving the growth of the APAC intraoperative imaging market.

Breakdown of supply-side primary interviews:
  • By Company Type: Tier 1: 48%, Tier 2: 36%, and Tier 3: 16%
  • By Designation: C-level: 10%, D-level: 14%, and Others: 76%
  • By Region: North America: 45%, Europe: 24%, APAC: 20%, Latin America: 7%, and the Middle East & Africa: 4%
The major players operating in the human organoids market are General Electric Company (US), Siemens Healthineers AG (Germany), Ziehm Imaging GmbH (Germany), Medtronic (Ireland), and Koninklijke Philips N.V. (Netherlands) were the top five players in the global intraoperative imaging market. Other notable companies are Canon Healthcare (Japan), Stryker (US), Brainlab AG (Germany), IMRIS (US), Shimadzu Corporation (Japan), Shenzhen Anke High-tech Co. (China), Hitachi, Ltd. (Japan), FUJIFILM Holdings (Japan), Carl Zeiss Meditec AG (Germany), Mindray Ltd. (US), Carestream Health (US), Analogic Corporation (US), Allengers Medical Systems Ltd. (India), Esaote SpA (Italy) and NeuroLogica Corporation (US).

Research Coverage

This report studies the intraoperative imaging market based on the product, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report

This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the human organoids market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
  1.2.1 MARKET SCOPE
FIGURE 1 MARKETS COVERED
  1.2.2 GEOGRAPHIC SCOPE
  1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY USED FOR THE STUDY
1.4 MAJOR MARKET STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
  2.1.1 SECONDARY DATA
    2.1.1.1 Secondary sources
  2.1.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARIES: INTRAOPERATIVE IMAGING MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  2.2.1 END USER -BASED MARKET ESTIMATION
  2.2.2 REVENUE MAPPING-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: INTRAOPERATIVE IMAGING MARKET
  2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

FIGURE 7 INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 8 INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 9 INTRAOPERATIVE IMAGING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING
THE FORECAST PERIOD

4 PREMIUM INSIGHTS

4.1 INTRAOPERATIVE IMAGING MARKET OVERVIEW
FIGURE 11 INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH
4.2 INTRAOPERATIVE IMAGING MARKET, BY PRODUCT
FIGURE 12 MOBILE C-ARMS TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
4.3 APAC: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY AND PRODUCT
FIGURE 13 JAPAN IS THE LARGEST MARKET FOR INTRAOPERATIVE IMAGING IN APAC
4.4 INTRAOPERATIVE IMAGING MARKET SHARE, BY END USER
FIGURE 14 HOSPITALS & DIAGNOSTIC CENTERS TO ACCOUNT FOR THE LARGEST MARKET SHARE DURING THE FORECAST PERIOD
4.5 GEOGRAPHICAL SNAPSHOT OF THE INTRAOPERATIVE IMAGING MARKET
FIGURE 15 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 INTRAOPERATIVE IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  5.2.1 DRIVERS
    5.2.1.1 Rising geriatric population and growth in the prevalence of chronic diseases
TABLE 1 AGE-RELATED DISEASES: PREVALENCE AND ESTIMATIONS
    5.2.1.2 Technological advancements in intraoperative imaging modalities
    5.2.1.3 Increasing demand for minimally invasive surgeries
    5.2.1.4 Rising investments/funds/grants by public-private organizations
TABLE 2 KEY INVESTMENTS BY GOVERNMENT BODIES IN THE INTRAOPERATIVE IMAGING MARKET
  5.2.2 RESTRAINTS
    5.2.2.1 High cost of intraoperative imaging systems
    5.2.2.2 Declining reimbursements and increasing regulatory burden
  5.2.3 OPPORTUNITIES
    5.2.3.1 High growth opportunities in emerging countries
    5.2.3.2 Adoption of AI and analytics in intraoperative imaging
  5.2.4 CHALLENGES
    5.2.4.1 Hospital budget cuts
    5.2.4.2 Dearth of trained professionals
    5.2.4.3 Increasing adoption of refurbished systems
5.3 REGULATORY SCENARIO
5.4 ECOSYSTEM COVERAGE
5.5 VALUE CHAIN ANALYSIS
5.6 PRICING ANALYSIS
TABLE 3 INTRAOPERATIVE IMAGING PRODUCTS PRICING ANALYSIS (USD, 2019)
5.7 PORTER’S 5 FORCE ANALYSIS

6 INTRAOPERATIVE IMAGING MARKET, BY PRODUCT

6.1 INTRODUCTION
TABLE 4 INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
6.2 MOBILE C-ARMS
  6.2.1 MULTI-FUNCTIONAL CAPABILITIES OF C-ARMS WILL INCREASE THEIR ADOPTION AMONG SURGEONS
TABLE 5 PRODUCT HIGHLIGHTS
TABLE 6 INTRAOPERATIVE IMAGING MARKET FOR MOBILE C-ARMS, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 INTRAOPERATIVE IMAGING MARKET FOR MOBILE C-ARMS, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 8 INTRAOPERATIVE IMAGING MARKET FOR MOBILE C-ARMS, BY END USER, 2018–2025 (USD MILLION)
6.3 ULTRASOUND SYSTEMS
  6.3.1 DIAGNOSTIC SUPERIORITY AND GROWING APPLICATIONS WILL INCREASE THE ADOPTION OF INTRAOPERATIVE ULTRASOUND
TABLE 9 INTRAOPERATIVE IMAGING MARKET FOR ULTRASOUND SYSTEMS, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 10 INTRAOPERATIVE IMAGING MARKET FOR ULTRASOUND SYSTEMS, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 INTRAOPERATIVE IMAGING MARKET FOR ULTRASOUND SYSTEMS, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 12 INTRAOPERATIVE IMAGING MARKET FOR ULTRASOUND SYSTEMS, BY END USER, 2018–2025 (USD MILLION)
  6.3.2 DROP IN PROBES
    6.3.2.1 Drop in Probes segment will dominate the ultrasound market in upcoming years
TABLE 13 INTRAOPERATIVE IMAGING MARKET FOR DROP IN PROBES, BY REGION, 2018–2025 (USD MILLION)
  6.3.3 LAPAROSCOPIC PROBES
    6.3.3.1 Laparoscopic probe utilization is augmented by rising number of related surgical procedures across key geographies.
TABLE 14 INTRAOPERATIVE IMAGING MARKET FOR LAPAROSCOPIC PROBES, BY REGION, 2018–2025 (USD MILLION)
  6.3.4 OTHER ULTRASOUND SYSTEMS
    6.3.4.1 Other ultrasound segment market will have smaller segment due to technical difficulties.
TABLE 15 INTRAOPERATIVE IMAGING MARKET FOR OTHER ULTRASOUND SYSTEMS, BY REGION, 2018–2025 (USD MILLION)
6.4 CT SCANNERS
  6.4.1 CT USE IN DIAGNOSTIC APPLICATIONS HAS RISEN SIGNIFICANTLY IN RECENT YEARS
TABLE 16 INTRAOPERATIVE IMAGING MARKET FOR CT SCANNERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 17 INTRAOPERATIVE IMAGING MARKET FOR CT SCANNERS, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 18 INTRAOPERATIVE IMAGING MARKET FOR CT SCANNERS, BY END USER, 2018–2025 (USD MILLION)
6.5 MRI SCANNERS
  6.5.1 FASTER SCAN TIMES AND INCREASED IMAGE QUALITY TO INCREASE
THE ADOPTION OF INTRAOPERATIVE MRI SYSTEMS
TABLE 19 INTRAOPERATIVE IMAGING MARKET FOR MRI SCANNERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 INTRAOPERATIVE IMAGING MARKET FOR MRI SCANNERS, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 21 INTRAOPERATIVE IMAGING MARKET FOR MRI SCANNERS, BY END USER, 2018–2025 (USD MILLION)
6.6 X-RAY SYSTEMS
  6.6.1 POSSIBILITY OF SIDE-EFFECTS DUE TO RADIATION EXPOSURE MAY HINDER MARKET GROWTH
TABLE 22 INTRAOPERATIVE IMAGING MARKET FOR X-RAY SYSTEMS, BY REGION, 2018–2025 (USD MILLION)
TABLE 23 INTRAOPERATIVE IMAGING MARKET FOR X-RAY SYSTEMS, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 24 INTRAOPERATIVE IMAGING MARKET FOR X-RAY SYSTEMS, BY END USER, 2018–2025 (USD MILLION)
6.7 OPTICAL IMAGING SYSTEMS
  6.7.1 GROWING DEMAND FOR NON-IONIZING IMAGING MODALITIES TO AID MARKET GROWTH
TABLE 25 INTRAOPERATIVE IMAGING MARKET FOR OPTICAL IMAGING SYSTEMS, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 INTRAOPERATIVE IMAGING MARKET FOR OPTICAL IMAGING SYSTEMS, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 27 INTRAOPERATIVE IMAGING MARKET FOR OPTICAL IMAGING SYSTEMS, BY END USER, 2018–2025 (USD MILLION)

7 INTRAOPERATIVE IMAGING MARKET, BY APPLICATION

7.1 INTRODUCTION
TABLE 28 INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
7.2 NEUROSURGERY
  7.2.1 NEUROSURGERY HOLDS THE LARGEST SHARE OF THE APPLICATIONS MARKET
TABLE 29 INTRAOPERATIVE IMAGING MARKET FOR NEUROSURGERY, BY REGION, 2018–2025 (USD MILLION)
7.3 CARDIOVASCULAR SURGERY
  7.3.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT THE MARKET GROWTH
TABLE 30 INTRAOPERATIVE IMAGING MARKET FOR CARDIOVASCULAR SURGERY, BY REGION, 2018–2025 (USD MILLION)
7.4 ORTHOPEDIC SURGERY
  7.4.1 RISING GERIATRIC POPULATION & RISING OBESITY RATES HAVE DRIVEN
THE NUMBER OF ORTHOPEDIC SURGERIES PERFORMED
TABLE 31 INTRAOPERATIVE IMAGING MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2018–2025 (USD MILLION)
7.5 SPINE SURGERY
  7.5.1 RISING NUMBER OF SPINE INJURIES AND GROWING ACCESS TO SPINE SURGERY WILL DRIVE MARKET GROWTH
TABLE 32 INTRAOPERATIVE IMAGING MARKET FOR SPINE SURGERY, BY REGION, 2018–2025 (USD MILLION)
7.6 SURGICAL ONCOLOGY
  7.6.1 INCREASING PREVALENCE OF CANCER WILL DRIVE THE MARKET GROWTH
TABLE 33 INTRAOPERATIVE IMAGING MARKET FOR SURGICAL ONCOLOGY, BY REGION, 2018–2025 (USD MILLION)
7.7 EMERGENCY AND TRAUMA SURGERIES
  7.7.1 EMERGENCY & TRAUMA CENTERS SUPPORTS THE GORWTH OF THIS SEGMENTS
TABLE 34 INTRAOPERATIVE IMAGING MARKET FOR EMERGENCY SURGERIES, BY REGION, 2018–2025 (USD MILLION)
7.8 ENT SURGERY
  7.8.1 GROWING FOCUS ON MINIMALLY INVASIVE AND IMAGE-GUIDED SURGERY SHOWCASE STRONG GROWTH POTENTIAL
TABLE 35 INTRAOPERATIVE IMAGING MARKET FOR ENT SURGERY, BY REGION, 2018–2025 (USD MILLION)
7.9 UROLOGICAL SURGERY
  7.9.1 GROWING INCIDENCE OF UROLOGICAL CONDITIONS TO AUGMENT POSITIVE GROWTH POTENTIAL OF RELATED SURGICAL PLATFORMS
TABLE 36 INTRAOPERATIVE IMAGING MARKET FOR UROLOGICAL SURGERY, BY REGION, 2018–2025 (USD MILLION)
7.10 HBP (HEPATO-PANCREATICO-BILIARY) SURGERY
  7.10.1 GROWING INCIDENCE OF UROLOGICAL SURGERY CONDISTIONS SHOWCASE STRONG GROWTH POTENTIAL
TABLE 37 INTRAOPERATIVE IMAGING MARKET FOR HPB SURGERY, BY REGION, 2018–2025 (USD MILLION)
7.11 COLORECTAL SURGERIES
  7.11.1 COLORECTAL SEGMENT IS LIKELY TO GROW AT SLOW GROWTH RATE IN UPCOMING YEAR
TABLE 38 INTRAOPERATIVE IMAGING MARKET FOR COLORECTAL SURGERIES, BY REGION, 2018–2025 (USD MILLION)
7.12 GENERAL SURGERY
  7.12.1 INCREASING NUMBER OF BARIATRIC SURGERY TO DRIVE MARKET GROWTH
TABLE 39 INTRAOPERATIVE IMAGING MARKET FOR GENERAL SURGERIES, BY REGION, 2018–2025 (USD MILLION)
7.13 OTHER APPLICATIONS
  7.13.1 OTHER APPLICATIONS SEGMENT IS LIKELY TO GROW AT SLOW GROWTH RATE IN UPCOMING YEAR
TABLE 40 INTRAOPERATIVE IMAGING MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)

8 INTRAOPERATIVE IMAGING MARKET, BY END USER

8.1 INTRODUCTION
TABLE 41 INTRAOPERATIVE IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2 HOSPITALS & DIAGNOSTIC CENTERS
  8.2.1 INCREASING NUMBER OF SURGERIES AND HIGH PURCHASING POWER TO SUPPORT THE GROWTH OF THIS SEGMENT
TABLE 42 INTRAOPERATIVE IMAGING MARKET FOR HOSPITALS & DIAGNOSTICS CENTERS, BY REGION, 2018–2025 (USD MILLION)
8.3 AMBULATORY SURGICAL CENTERS & CLINICS
  8.3.1 INCREASING NUMBER OF ASCS LIKELY TO DRIVE MARKET GROWTH
TABLE 43 INTRAOPERATIVE IMAGING MARKET FOR AMBULATORY SURGICAL CENTERS & CLINICS, BY REGION, 2018–2025 (USD MILLION)
8.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
  8.4.1 BUDGETARY RESTRICTIONS OF RESEARCHERS ARE LIMITING THE ADOPTION OF HIGH-END INTRAOPERATIVE IMAGING PRODUCTS
TABLE 44 INTRAOPERATIVE IMAGING MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018–2025 (USD MILLION)

9 INTRAOPERATIVE IMAGING MARKET, BY REGION

9.1 INTRODUCTION
TABLE 45 INTRAOPERATIVE IMAGING MARKET, BY REGION, 2018–2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 17 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET SNAPSHOT
TABLE 46 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 47 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 48 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 49 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)
  9.2.1 US
    9.2.1.1 The US dominates the North American market
TABLE 50 INCREASE IN TARGET POPULATION/DISEASE PREVALENCE IN THE US
TABLE 51 US: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
  9.2.2 CANADA
    9.2.2.1 A dearth of radiologists and long waiting times restrain market growth in Canada
TABLE 52 INCREASE IN TARGET POPULATION/DISEASE PREVALENCE IN CANADA
TABLE 53 CANADA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
9.3 EUROPE
TABLE 54 EUROPE: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55 EUROPE: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 56 EUROPE: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 57 EUROPE: INTRAOPERATIVE IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)
  9.3.1 GERMANY
    9.3.1.1 Germany holds the largest share of the market in Europe
TABLE 58 INCREASE IN TARGET POPULATION/DISEASE PREVALENCE IN GERMANY
TABLE 59 GERMANY: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
  9.3.2 UK
    9.3.2.1 Government initiatives to support market growth in the UK
TABLE 60 UK: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
  9.3.3 FRANCE
    9.3.3.1 Availability of funding, strong player presence, and government support are key drivers in France
TABLE 61 FRANCE: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
  9.3.4 ITALY
    9.3.4.1 Favorable regulatory policies likely to support market growth
TABLE 62 ITALY: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
  9.3.5 SPAIN
    9.3.5.1 Preference for new equipment likely to increase the market growth
TABLE 63 SPAIN: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
  9.3.6 REST OF EUROPE
TABLE 64 ROE: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 18 ASIA PACIFIC: INTRAOPERATIVE IMAGING MARKET SNAPSHOT
TABLE 65 APAC: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 66 APAC: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 67 APAC: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 68 APAC: INTRAOPERATIVE IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)
  9.4.1 JAPAN
    9.4.1.1 Japan dominates the APAC market
TABLE 69 JAPAN: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
  9.4.2 CHINA
    9.4.2.1 Government initiatives and investments support the growth of the Chinese market
TABLE 70 CHINA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
  9.4.3 INDIA
    9.4.3.1 Rising disease incidence and growing awareness support market growth; uncertainties in healthcare policies and uneven coverage pose challenges
TABLE 71 INDIA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
  9.4.4 AUSTRALIA
    9.4.4.1 Support for R&D and equipment purchases drives the market growth in Australia
TABLE 72 AUSTRALIA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
  9.4.5 SOUTH KOREA
    9.4.5.1 Supportive government initiatives expected to impact market growth positively
TABLE 73 SOUTH KOREA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
  9.4.6 REST OF ASIA PACIFIC
TABLE 74 ROAPAC: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
9.5 LATIN AMERICA
TABLE 75 LATIN AMERICA: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 76 LATAM: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 77 LATAM: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 78 LATAM: INTRAOPERATIVE IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)
  9.5.1 BRAZIL
    9.5.1.1 Growing disease burden and rising awareness to support market growth in Brazil
TABLE 79 BRAZIL: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
  9.5.2 MEXICO
    9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth in Mexico
TABLE 80 MEXICO: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
  9.5.3 REST OF LATIN AMERICA
TABLE 81 ROLATAM: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
  9.6.1 RISING DISPOSABLE INCOME AND INFRASTRUCTURAL DEVELOPMENT TO CONTRIBUTE TO MARKET GROWTH
TABLE 82 MEA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 83 MEA: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 84 MEA: INTRAOPERATIVE IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
FIGURE 19 KEY DEVELOPMENTS IN THE INTRAOPERATIVE IMAGING MARKET
(2017–2020)
10.2 GLOBAL MARKET SHARE ANALYSIS (2019)
FIGURE 20 GE HEALTHCARE HELD THE LEADING POSITION IN THE INTRAOPERATIVE IMAGING MARKET IN 2019
10.3 COMPETITIVE SCENARIO (2017–2020)
  10.3.1 KEY PRODUCT LAUNCHES (2017–2020)
  10.3.2 KEY EXPANSIONS (2017–2020)
  10.3.3 KEY ACQUISITIONS (2017–2020)
  10.3.4 KEY AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS (2017–2020)
10.4 COMPETITIVE LEADERSHIP MAPPING
10.5 VENDOR INCLUSION CRITERIA
  10.5.1 STARS
  10.5.2 EMERGING LEADERS
  10.5.3 PERVASIVE PLAYERS
  10.5.4 PARTICIPANTS
FIGURE 21 INTRAOPERATIVE IMAGING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
10.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2019)
  10.6.1 PROGRESSIVE COMPANIES
  10.6.2 STARTING BLOCKS
  10.6.3 RESPONSIVE COMPANIES
  10.6.4 DYNAMIC COMPANIES
FIGURE 22 INTRAOPERATIVE IMAGING MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019 (SME/START-UPS)

11 COMPANY PROFILES

(Business overview, Products offered, Recent developments, MNM view)*
11.1 GENERAL ELECTRIC COMPANY
FIGURE 23 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
11.2 SIEMENS HEALTHINEERS AG
FIGURE 24 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
11.3 CANON MEDICAL SYSTEMS CORPORATION
FIGURE 25 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
11.4 MEDTRONIC PLC
FIGURE 26 MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
11.5 KONINKLIJKE PHILIPS N.V.
FIGURE 27 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
11.6 CARESTREAM HEALTH
11.7 SHIMADZU CORPORATION
FIGURE 28 SHIMADZU CORPORATION: COMPANY SNAPSHOT
11.8 SHENZHEN ANKE HIGH-TECH CO., LTD.
11.9 BRAINLAB AG
11.10 ZIEHM IMAGING GMBH
11.11 HITACHI, LTD.
FIGURE 29 HITACHI, LTD.: COMPANY SNAPSHOT
11.12 FUJIFILM HOLDINGS CORPORATION
FIGURE 30 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
11.13 IMRIS, DEERFIELD IMAGING, INC.
11.14 STRYKER CORPORATION
FIGURE 31 STRYKER CORPORATION: COMPANY SNAPSHOT (2019)
11.15 NEUROLOGICA CORPORATION
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
11.16 OTHER COMPANIES
  11.16.1 ESAOTE SPA
  11.16.2 ANALOGIC CORPORATION
  11.16.3 MINDRAY MEDICAL INTERNATIONAL LIMITED
  11.16.4 CARL ZEISS MEDITEC AG
  11.16.5 ALLENGERS MEDICAL SYSTEMS LTD.

12 APPENDIX

12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS


More Publications